TMEM184B Antibody, FITC conjugated
-
中文名稱：TMEM184B兔多克隆抗體, FITC偶聯(lián)
-
貨號：CSB-PA023770LC01HU
-
規(guī)格：￥880
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) TMEM184B Polyclonal antibody
-
Uniprot No.：
-
基因名：TMEM184B
-
別名：TMEM184B; C22orf5; PSEC0108; Transmembrane protein 184B; Putative MAPK-activating protein FM08
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human Transmembrane protein 184B protein (311-407AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：FITC
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式：Liquid
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情
-
功能：May activate the MAP kinase signaling pathway.
-
基因功能參考文獻(xiàn)：
- Data shows that miR-26a and miR-26b were significantly downregulated and their direct target, TMEM184B significantly up-regulated in oral squamous cell carcinoma cells. PMID: 25668004
- C22orf5 (FM08) represents a novel gene found during a screening of gene that activate the MAPK pathway. PMID: 12761501
-
亞細(xì)胞定位：Membrane; Multi-pass membrane protein.
-
蛋白家族：TMEM184 family
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
